Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Activist investor Elliott Investment Management has built a significant stake in Bio-Rad Laboratories and is expected to push for improvements. The company's Sartorius stake is valued at roughly $5 billion, nearly equal to Bio-Rad's $6.6 billion market cap. Bio-Rad shares surged 12.94% on the news, though the stock has fallen over 70% from its 2021 pandemic peak. The company faces margin pressures with 2026 guidance of 10-12%, well below historical levels and industry peers.

05/18/2026, 2:34 PM • Benzinga

[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global cell culture media bags market is valued at USD 1.30 billion in 2025 and is projected to reach USD 2.28 billion by 2035, growing at a CAGR of 5.8%. Growth is driven by increased R&D investments in life sciences, adoption of single-use bioprocessing technologies, and automation trends in biopharmaceutical manufacturing. Single-use bags and EVA materials dominate the market segments, with North America leading in market share and Asia Pacific showing the highest growth rate.

04/29/2026, 12:30 AM • GlobeNewswire

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

The global Pharmaceutical Microbiology QC Testing Market is projected to grow from USD 5.08 billion in 2025 to USD 17.65 billion by 2035, at a CAGR of 13.27%. Growth is driven by increased regulatory oversight, laboratory automation, antimicrobial resistance concerns, and adoption of advanced technologies like AI-enabled molecular platforms and MALDI-TOF mass spectrometry. North America leads with 39.12% market share, while Asia Pacific is expected to grow fastest at 14.33% CAGR.

03/10/2026, 2:00 PM • GlobeNewswire

Cell Therapy Processing Market to Grow 21.4% Annually Through 2030

The global cell therapy processing market is projected to grow from $2.7 billion in 2025 to $7.1 billion by 2030, at a CAGR of 21.4%. Growth is driven by rising demand for advanced cell therapies including CAR-T, increasing R&D investments, expanding clinical trials, and an aging population with chronic diseases. Key challenges include complex manufacturing, regulatory hurdles, and workforce shortages. North America leads the market with the highest share.

02/05/2026, 1:47 PM • GlobeNewswire

Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica

The global single-use bioprocessing market is expected to grow from USD 30.12 billion in 2025 to USD 122.92 billion by 2035 at a CAGR of 15.1%. Driven by technological breakthroughs in bioreactor scalability (up to 6,000L), 40-50% CAPEX reductions, and FDA approvals of 16 single-use-manufactured biologics in 2024, the market is becoming the standard for commercial biomanufacturing. Major players are expanding capacity significantly, with CDMOs like WuXi Biologics managing substantial backlogs.

01/20/2026, 12:38 PM • GlobeNewswire

Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

The global bioconjugation market is projected to grow from USD 5.46 billion in 2025 to USD 14.51 billion by 2033, at a CAGR of 13.05%. Growth is driven by increasing demand for targeted therapeutics, antibody-drug conjugates, advances in conjugation chemistries, and biopharmaceutical R&D investments. North America leads with 45.50% market share, while Asia Pacific is expected to grow fastest at 14.98% CAGR. High costs and technical complexity remain challenges.

01/19/2026, 11:00 AM • GlobeNewswire

Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

The global continuous bioprocessing market is projected to grow from USD 319.77 million in 2025 to USD 2,331.98 million by 2035 at a CAGR of 21.98%. Driven by demand for biosimilars and complex biologics, manufacturers are shifting from traditional fed-batch to continuous methods, achieving 50% cost reductions and significant sustainability improvements. North America leads with 39% market share, while Asia Pacific rapidly expands capacity. Major pharmaceutical and biotech companies are deploying billions in capital investments to modernize manufacturing infrastructure.

01/16/2026, 12:38 PM • GlobeNewswire

Sterile Bioprocess Filtration Market to Hit USD 21.20 Billion by 2032, Driven by Rising Biologics Production and Adoption of Single Use Filtration Technologies - SNS Insider

The global sterile bioprocess filtration market is projected to grow from USD 5.32 billion in 2024 to USD 21.20 billion by 2032, driven by increasing biologics production, single-use technologies, and advances in membrane filtration.

12/14/2025, 8:58 AM • GlobeNewswire

Cell Culture Microcarriers Market Size Leads at 8.54% CAGR by 2034 – Towards Healthcare

The global cell culture microcarriers market is projected to grow from USD 3.45 billion in 2025 to USD 7.2 billion by 2034, with an 8.54% CAGR, driven by advancements in biopharmaceuticals, cell therapies, and regenerative medicine research.

12/01/2025, 11:00 AM • GlobeNewswire

Cell Harvesting Market to Reach USD 20.08 Billion, Growing at a Strong 12.95% CAGR by 2034

The global cell harvesting market is projected to grow from $5.94 billion in 2024 to $20.08 billion by 2034, with a 12.95% CAGR, driven by increasing demand for regenerative medicine, cell-based therapies, and technological advancements in cell research.

11/17/2025, 11:00 AM • GlobeNewswire

Filtration in Biologics Market: Trends, Growth Drivers and Opportunities (2024–2034)

The filtration in biologics market is projected to experience significant growth from 2024 to 2034, driven by increasing demand for monoclonal antibodies, vaccines, and cell and gene therapies, with North America leading and Asia Pacific showing the fastest growth potential.

10/24/2025, 10:00 AM • GlobeNewswire

Biologics Safety Testing Market to Rise at 13.64% CAGR, Soars USD 14.45 Bn by 2034

The global biologics safety testing market is projected to grow from $4.58 billion in 2025 to $14.45 billion by 2034, with a 13.64% CAGR. North America dominates the market, driven by biopharmaceutical R&D and technological advancements, while Asia-Pacific shows rapid growth potential.

10/16/2025, 11:00 AM • GlobeNewswire